Regulatory education
FDA Veterinarian Amber McCoig examines the policies included in this guidance and what they mean for veterinarians and their teams in the webinar. She also discusses how the agency’s final guidance tries to balance the risks of compounding animal drugs from bulk substances when there is no FDA-approved drug available, and why the FDA can’t assure the safety, effectiveness or quality of bulk drug substances.
Source: AVMA, November 30, 2022. Link.